Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion

Journal of Experimental Medicine

Volumn 179, Issue 2, 1994, Pages 703-708

  Dubucquoi, Sylvain ^a,b   Desreumaux, Pierre ^a,b   Janin, Anne ^b   Klein, Olivier ^b   Goldman, Michel ^c   Tavernier, Jan ^d   Capron, André ^a   Capron, Monique ^a  

^a INSTITUT PASTEUR DE LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c ERASME HOSPITAL   (Belgium)

^d Roche Research   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 5; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CYSTITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; EOSINOPHILIA; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN PRODUCTION; IMMUNOGOLD STAINING; MAST CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0027979447     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.179.2.703     Document Type: Article

References (19)

1. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophil precursors. J. Exp. Med. 167:43.
2. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.D. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219.
3. Plaut, M., J.H. Pierce, C.J. Watson, J. Hanley-Hyde, R.P. Nordan, and W.E. Paul. 1989. Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores. Nature (Lond.). 339:64.
4. Desreumaux, P., A. Janin, J.F. Colombel, L. Prin, J. Plumas, D. Emilie, G. Torpier, A. Capron, and M. Capron. 1992. Interleukin 5 messenger RNA expression by eosinophils in the intestinal mucosa of patients with coeliac disease. J. Exp. Med. 175:293.
5. Broide, D.H., M.M. Paine, and G.S. Firestein. 1992. Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90:1414.
6. Desreumaux, P., A. Janin, S. Dubucquoi, M.C. Copin, G. Torpier, A. Capron, M. Capron, and L. Prin. 1993. Synthesis of interleukin 5 by activated eosinophils in patients with eosinophilic heart diseases. Blood. 82:1553.
7. Prin, L., M. Capron, A.B. Tonnel, O. Bletry, and A. Capron. 1983. Heterogeneity of human blood eosinophils: variability in cell density and cytotoxic ability in relation to the level and the origin of the hypereosinophilia. Int. Arch. Allergy Appl. Immunol. 72:336.
8. Mason, D.Y., and R. Sammons. 1978. Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular contents. J. Clin. Pathol. 31:454.
9. Torpier, G., J.F. Colombel, C. Mathieu-Chandelier, M. Capron, J.P. Dessaint, A. Cortot, J.C. Paris, and A. Capron. 1988. Eosinophilic gastroenteritis: ultrastructural evidence for a selective release of eosinophil major basic protein. Clin. Exp. Immunol. 74:404.
10. Tai, P.C., C.J.F. Spry, C. Peterson, P. Venge, and I. Olsson. 1984. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature (Lond.). 308:182.
11. Schandené, L., A. Ferster, F. Mascart-Lemone, A. Crusiaux, C. Gérard, A. Marchant, M. Lybin, T. Velu, E. Sariban, and M. Goldman. 1993. T helper type 2-like cells and therapeutic effects of interferon-γ in combined immunodeficiency with hypereosinophilia (Omenn's syndrome). Eur. J. Immunol. 23:56.
12. Moqbel, R., Q. Hamid, S. Ying, J. Barkans, A. Hartnell, A. Tsicopoulos, A.J. Wardlaw, and A.B. Kay. 1991. Expression of mRNA and immunoreactivity for the granulocyte macrophage colony-stimulating factor in activated human eosinophils. J. Exp. Med. 174:749.
13. Braun, K.R., M. Francini, F. Erard, S. Rihs, I.J.M. De Vries, K. Blaser, T.T. Hansel, and C. Walker. 1993. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur. J. Immunol. 23:956.
14. Gordon, J.R., and S.J. Galli. 1991. Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/ cachectin by mouse mast cells stimulated via the FcεRI. A mechanism for the sustained action of mast cell-derived TNF-α during IgE-dependent biological responses. J. Exp. Med. 174:103.
15. Abu Ghazaleh, R., T. Fusisawa, J. Mestecky, A. Kyle, and G.J. Gleich. 1989. IgA-induced eosinophil degranulation. J. Immunol. 142:2393.
16. Tomassini, M., A. Tsicopoulos, E. Van der Vorst, J.P. Kusnierz, J.P. Papin, A. Capron, and M. Capron. 1991. Release of granule protein by eosinophils from allergic and non allergic patients with hypereosinophilia on immunoglobulin-dependent activation. J. Allergy Clin. Immunol. 88:365.
17. Brandtzaeg, P., T.S. Halstensen, and K. Kett. 1989. Immunobiology and immunopathology of human gut mucosa: humoral immunity and intra-epithelial lymphocytes. Gastroenterology. 97:1562.
18. Rubin, L., and M.B. Pincus. 1974. Eosinophilic cystitis: the relationship of allergy to eosinophilic cystitis and the pathophysiology of eosinophilia. J. Urol. 112:457.
19. Schreiber, S., A. Readler, W.F. Stenson, and R.P. MacDermott. 1992. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol. Clin. North Am. 21:451.